Seek Returns

ARGX vs. MTD: argenx vs. Mettler-Toledo Stock Comparison

How do argenx (ARGX) and Mettler-Toledo (MTD) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

argenx (ARGX) and Mettler-Toledo (MTD) both fall under the Pharmaceuticals, Biotechnology & Life Sciences industry group, but ARGX is classified in Biotechnology while MTD is classified in Life Sciences Tools & Services.

Mettler-Toledo (MTD) trades as ordinary local shares, while argenx (ARGX) trades as an ADR — compare with FX exposure, depositary-program fees, and dividend-withholding-tax differences in mind.

Company profile comparison for argenx (ARGX) and Mettler-Toledo (MTD)
Profile ItemARGXMTD
Nameargenx SE American Depositary ReceiptMettler-Toledo International Inc.
Country/RegionNetherlandsSwitzerland
GICS SectorHealth CareHealth Care
GICS Industry GroupPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnologyLife Sciences Tools & Services
GICS Sub-IndustryBiotechnologyLife Sciences Tools & Services
Market Capitalization58.31 billion USD34.25 billion USD
CurrencyUSDUSD
ExchangeNasdaqNYSE
Listing DateMay 18, 2017November 14, 1997
Security TypeADRCommon Stock

Price Performance

Cumulative Growth

ARGX
MTD
GSPC
Loading price history…
argenx (ARGX) vs. Mettler-Toledo (MTD), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…
Trailing total returns for argenx (ARGX) and Mettler-Toledo (MTD). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…
Calendar-year total returns for argenx (ARGX) and Mettler-Toledo (MTD). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for argenx (ARGX) and Mettler-Toledo (MTD)
MetricARGXMTD
Total Return (1Y)11.91%21.58%
Total Return (3Y, Annualized)25.68%19.54%
Total Return (5Y, Annualized)24.22%2.36%

Risk Profile

Drawdown History

ARGX
MTD
GSPC
Loading price history…
argenx (ARGX) vs. Mettler-Toledo (MTD), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…
Distribution of monthly total returns for argenx (ARGX) and Mettler-Toledo (MTD). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Risk profile metrics for argenx (ARGX) and Mettler-Toledo (MTD)
MetricARGXMTD
Volatility (1Y, Annualized)37.87%31.70%
Beta (5Y)0.451.15
Max Drawdown (5Y)-38.20%-43.47%
Avg. Volume (3M)359.84K197.80K

Risk-Adjusted Performance

Risk-Return Positioning

Loading chart…
ARGX and MTD are plotted by 1-year volatility (risk) and 1-year return. The dashed Capital Allocation Line runs from the risk-free rate through the shared industry median.

Risk-Adjusted Metrics

Risk-adjusted metrics for argenx (ARGX) and Mettler-Toledo (MTD)
MetricARGXMTD
Sharpe Ratio (1Y)0.200.55
Sortino Ratio (1Y)0.310.75

Profitability

ROE (TTM)

Neither argenx (ARGX) nor Mettler-Toledo (MTD) reports a ROE value for this period, so a direct comparison isn’t possible.

ARGX

Pharmaceuticals, Biotechnology & Life Sciences industry group

--

Max
109.18%
Q3
6.23%
Median
-26.66%
Q1
-64.05%
Min
-167.77%
ARGX
--

MTD

Pharmaceuticals, Biotechnology & Life Sciences industry group

--

Max
109.18%
Q3
6.23%
Median
-26.66%
Q1
-64.05%
Min
-167.77%
MTD
--
Loading chart…
argenx (ARGX) vs. Mettler-Toledo (MTD): Neither stock reports ROE, so the chart shows available benchmark boxes without value markers.

Net Margin (TTM)

Both argenx (ARGX) at 31.73% and Mettler-Toledo (MTD) at 22.25% keep an unusually large share of revenue as bottom-line profit — each net margin clears its industry’s benchmark range.

ARGX

Pharmaceuticals, Biotechnology & Life Sciences industry group

31.73%

ARGX
31.73%
Max
18.05%
Q3
4.78%
Median
0.00%
Q1
-4.14%
Min
-17.05%

MTD

Pharmaceuticals, Biotechnology & Life Sciences industry group

22.25%

MTD
22.25%
Max
18.05%
Q3
4.78%
Median
0.00%
Q1
-4.14%
Min
-17.05%
Loading chart…
argenx (ARGX) vs. Mettler-Toledo (MTD): A comparison of their net margin against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Operating Margin (TTM)

Both argenx (ARGX) at 36.27% and Mettler-Toledo (MTD) at 28.70% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.

ARGX

Pharmaceuticals, Biotechnology & Life Sciences industry group

36.27%

Max
83.12%
ARGX
36.27%
Q3
14.77%
Median
0.00%
Q1
-78.82%
Min
-207.40%

MTD

Pharmaceuticals, Biotechnology & Life Sciences industry group

28.70%

Max
83.12%
MTD
28.70%
Q3
14.77%
Median
0.00%
Q1
-78.82%
Min
-207.40%
Loading chart…
argenx (ARGX) vs. Mettler-Toledo (MTD): A comparison of their operating margin against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Profitability Metrics

Profitability metrics for argenx (ARGX) and Mettler-Toledo (MTD)
MetricARGXMTD
ROE (TTM)----
ROA (TTM)--20.09%
Net Margin (TTM)31.73%22.25%
Operating Margin (TTM)36.27%28.70%
Gross Margin (TTM)59.84%59.16%

Growth

Revenue Growth

argenx (ARGX) at 89.64% sits in the top revenue growth quartile, while Mettler-Toledo (MTD) at 3.98% is closer to the peer norm — faster top-line expansion for ARGX.

Loading chart…
argenx (ARGX) vs. Mettler-Toledo (MTD): A comparison of their Revenue Growth across different time periods.

EPS Growth

Both argenx (ARGX) at 53.13% and Mettler-Toledo (MTD) at 3.88% land near their industries' usual EPS growth ranges, so bottom-line momentum looks broadly in line with peers on both sides.

Loading chart…
argenx (ARGX) vs. Mettler-Toledo (MTD): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for argenx (ARGX) and Mettler-Toledo (MTD)
MetricARGXMTD
Revenue Growth (YoY)89.64%3.98%
Revenue Growth (3Y CAGR)116.25%0.90%
EPS Growth (YoY)53.13%3.88%
EPS Growth (3Y CAGR)--3.06%

Financial Strength

Current Ratio (MRQ)

Short-term liquidity can only be read on one side of this pairing: Mettler-Toledo (MTD) shows current ratio of 1.10 against its industry benchmark, while argenx (ARGX) has no reading this period.

ARGX

Pharmaceuticals, Biotechnology & Life Sciences industry group

--

Max
25.13
Q3
12.13
Median
5.52
Q1
2.47
Min
0.10
ARGX
--

MTD

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.10

Max
25.13
Q3
12.13
Median
5.52
Q1
2.47
MTD
1.10
Min
0.10
Loading chart…
argenx (ARGX) vs. Mettler-Toledo (MTD): ARGX does not report current ratio, so it has no value marker; MTD is benchmarked against the Pharmaceuticals, Biotechnology & Life Sciences industry group.

Debt / Equity (MRQ)

argenx (ARGX) at 0.01 keeps leverage in the lower quartile, while Mettler-Toledo (MTD) at 26.06 is above its industry debt-to-equity ratio range.

ARGX

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.01

Max
1.42
Q3
0.65
Median
0.15
Q1
0.02
ARGX
0.01
Min
0.00

MTD

Pharmaceuticals, Biotechnology & Life Sciences industry group

26.06

MTD
26.06
Max
1.42
Q3
0.65
Median
0.15
Q1
0.02
Min
0.00
Loading chart…
argenx (ARGX) vs. Mettler-Toledo (MTD): A comparison of their debt-to-equity ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Financial Strength Metrics

Financial strength metrics for argenx (ARGX) and Mettler-Toledo (MTD)
MetricARGXMTD
Current Ratio (MRQ)--1.10
Debt / Equity (MRQ)0.0126.06
Net Debt / EBITDA-2.701.58

Dividends

Dividend Yield (TTM)

Neither argenx (ARGX) nor Mettler-Toledo (MTD) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

ARGX

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

ARGX
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

MTD

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

MTD
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
argenx (ARGX) vs. Mettler-Toledo (MTD): A comparison of their dividend yield against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Dividend Payout Ratio (TTM)

Neither argenx (ARGX) nor Mettler-Toledo (MTD) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

ARGX

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

ARGX
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

MTD

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

MTD
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
argenx (ARGX) vs. Mettler-Toledo (MTD): A comparison of their payout ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Dividend Metrics

Dividend metrics for argenx (ARGX) and Mettler-Toledo (MTD)
MetricARGXMTD
Dividend Yield (TTM)0.00%0.00%
Dividend Payout Ratio (TTM)0.00%0.00%

Valuation

P/E Ratio (TTM)

Both argenx (ARGX) at 32.12 and Mettler-Toledo (MTD) at 37.38 land around their industries’ usual P/E ratio levels — neither is getting a clear earnings-multiple discount or premium versus peers.

ARGX

Pharmaceuticals, Biotechnology & Life Sciences industry group

32.12

Max
85.34
Q3
43.46
ARGX
32.12
Median
26.69
Q1
13.30
Min
0.07

MTD

Pharmaceuticals, Biotechnology & Life Sciences industry group

37.38

Max
85.34
Q3
43.46
MTD
37.38
Median
26.69
Q1
13.30
Min
0.07
Loading chart…
argenx (ARGX) vs. Mettler-Toledo (MTD): A comparison of their P/E ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

P/S Ratio (TTM)

On P/S ratio, both argenx (ARGX) at 9.86 and Mettler-Toledo (MTD) at 8.16 are priced roughly in line with their industries — neither looks cheap nor rich on a sales basis.

ARGX

Pharmaceuticals, Biotechnology & Life Sciences industry group

9.86

Max
58.18
Q3
25.77
ARGX
9.86
Median
7.30
Q1
3.01
Min
0.01

MTD

Pharmaceuticals, Biotechnology & Life Sciences industry group

8.16

Max
58.18
Q3
25.77
MTD
8.16
Median
7.30
Q1
3.01
Min
0.01
Loading chart…
argenx (ARGX) vs. Mettler-Toledo (MTD): A comparison of their P/S ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

P/B Ratio (MRQ)

Measured against book value, both argenx (ARGX) at 172.23 and Mettler-Toledo (MTD) at 442.71 look expensive — each P/B ratio sits above its industry’s benchmark range.

ARGX

Pharmaceuticals, Biotechnology & Life Sciences industry group

172.23

ARGX
172.23
Max
13.53
Q3
6.54
Median
3.25
Q1
1.69
Min
-5.59

MTD

Pharmaceuticals, Biotechnology & Life Sciences industry group

442.71

MTD
442.71
Max
13.53
Q3
6.54
Median
3.25
Q1
1.69
Min
-5.59
Loading chart…
argenx (ARGX) vs. Mettler-Toledo (MTD): A comparison of their P/B ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Valuation Metrics

Valuation metrics for argenx (ARGX) and Mettler-Toledo (MTD)
MetricARGXMTD
P/E Ratio (TTM)32.1237.38
P/S Ratio (TTM)9.868.16
P/B Ratio (MRQ)172.23442.71
Free Cash Flow Yield (TTM)--1.97%